Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-31
2011-05-31
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S184000, C546S192000, C546S195000, C546S196000, C546S198000, C514S315000, C514S317000, C514S319000
Reexamination Certificate
active
07951823
ABSTRACT:
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for, using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.
REFERENCES:
patent: 5523308 (1996-06-01), Costanzo et al.
patent: 5705487 (1998-01-01), Schacht et al.
patent: 5707966 (1998-01-01), Schacht et al.
patent: 5710130 (1998-01-01), Schacht et al.
patent: 5726159 (1998-03-01), Schacht et al.
patent: 5874585 (1999-02-01), Gyorkos et al.
patent: 5914319 (1999-06-01), Schacht et al.
patent: 6022861 (2000-02-01), Scarborough et al.
patent: 6211154 (2001-04-01), Scarborough et al.
patent: 6323219 (2001-11-01), Costanzo
patent: 6469036 (2002-10-01), Costanzo et al.
patent: 2003/0216325 (2003-11-01), Saksena et al.
patent: 2004/0167201 (2004-08-01), Sharma et al.
patent: 2004/0186060 (2004-09-01), Duncan et al.
patent: 2006/0275366 (2006-12-01), Malcolm et al.
patent: 2007/0032433 (2007-02-01), Saksena et al.
patent: 2007/0276002 (2007-11-01), Tully et al.
patent: 2008/0176901 (2008-07-01), Tully et al.
patent: 0291234 (1994-03-01), None
patent: 0 672 658 (1995-09-01), None
patent: 0 743 320 (1996-11-01), None
patent: 1 114 822 (2001-07-01), None
patent: 1 157 998 (2001-11-01), None
patent: 08-020597 (1996-01-01), None
patent: 95/23608 (1995-09-01), None
patent: 95/33763 (1995-12-01), None
patent: WO 96/11697 (1996-04-01), None
patent: 96/16080 (1996-05-01), None
patent: WO 96/40741 (1996-12-01), None
patent: WO 96/40742 (1996-12-01), None
patent: WO 96/40744 (1996-12-01), None
patent: WO 96/40748 (1996-12-01), None
patent: 97/17363 (1997-05-01), None
patent: WO 97/31939 (1997-09-01), None
patent: WO 97/48687 (1997-12-01), None
patent: WO 98/07308 (1998-02-01), None
patent: 98/17679 (1998-04-01), None
patent: 98/24806 (1998-06-01), None
patent: 98/50420 (1998-11-01), None
patent: WO 98/49190 (1998-11-01), None
patent: 99/07734 (1999-02-01), None
patent: 00/09543 (2000-02-01), None
patent: 00/09558 (2000-02-01), None
patent: WO 00/23421 (2000-04-01), None
patent: WO 00/39124 (2000-07-01), None
patent: WO 00/44733 (2000-08-01), None
patent: 01/02424 (2001-01-01), None
patent: WO 01/27096 (2001-04-01), None
patent: 01/40262 (2001-06-01), None
patent: WO 01/44226 (2001-06-01), None
patent: WO 02/08244 (2002-01-01), None
patent: 02/018369 (2002-03-01), None
patent: 02/079146 (2002-10-01), None
patent: 03/006490 (2003-01-01), None
patent: 03/013571 (2003-02-01), None
patent: WO 03/062265 (2003-07-01), None
patent: 03/072528 (2003-09-01), None
patent: WO 2005/023804 (2005-03-01), None
patent: 2005/035525 (2005-04-01), None
patent: 2005/037860 (2005-04-01), None
patent: 2005/058821 (2005-06-01), None
patent: WO 2005/076886 (2005-08-01), None
patent: 2005/087721 (2005-09-01), None
patent: 2005/090329 (2005-09-01), None
patent: 2005/113581 (2005-12-01), None
patent: WO 2006/006644 (2006-01-01), None
patent: 2006/108643 (2006-10-01), None
patent: 2007/140117 (2007-12-01), None
patent: 2008/085608 (2008-07-01), None
patent: 2008/097673 (2008-08-01), None
patent: 2008/097676 (2008-08-01), None
Costanzo, et al., “Potent, Small-Molecule Inhibitors of Human Mast cell Tryptase. Antiasthmatic Action of a Dipeptide-Based Transition-State Analogue Containing a Benzothiazole Ketone”,J. Med. Chem., vol. 46, pp. 3865-3876, 2003.
Donnelly, et al., “Therapy for chronic Obstructive Pulmonary Disease in the 21st Century”,Drugs, vol. 63, No. 19, 2003, pp. 1973-1998.
Edwards, et al., “Discovery and Biological Activity of Orally Active Petidyl Trifluoromethyl Ketone Inhibitors of Human Neutrophil Elastase”,J. Med. Chem. 1997 vol. 40, pp. 1876-1885.
Costanzo, et al., “In-Depth Study of Tripeptide-Based α-Ketoheterocycles as Inhibitors of Thrombin. Effective Utilization of the S1' Subsite and Its Implications to Structure-Based Drug Design”,J. Med. Chem., vol. 48, pp. 1984-2008, 2005.
U.S. Appl. No. 11/749,001, filed May 15, 2007 in the name of David C. Tully, et al.
Planes et al.; “Regulation of the Epithelial Na+ Channel by Peptidases”, Current Topics in Developmental Biology; 2007; vol. 78:23-46; pp. 1-19, NIH Public Access.
English translation of JP8020597 (JP1996020597A); Meiji Seika Kaisha Ltd.; published Jan. 23, 1996.
U.S. Appl. No. 12/525,991, filed Jan. 4, 2008 in the name of David C. Tully et al. (P1272).
U.S. Appl. No. 12/526,029, filed Jan. 7, 2008 in the name of David C. Tully et al. (P1284).
Schweinitz et al., “New Substrate Analogue Inhibitors of Factor Xa Containing 4-Amidinobenzylamide as P1 Residue: Part 1”; Medicinal Chemistry, vol. 2, No. 4, pp. 349-361, 2006.
Bursulaya Badry
Chatterjee Arnab K.
Petrassi Hank Michael James
Spraggon Glen
Tully David C.
Genomics Institute of the Novartis Research Foundation
IRM LLC
Shameem Golam M
Tongco Wu Emily
LandOfFree
Compounds and compositions as channel activating protease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and compositions as channel activating protease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as channel activating protease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2624585